Pyrazolopyridine compound and processes for preparation thereof

Abstract From the Canadian patent

There are described pyrazolopyridine, compounds of the formula: wherein R1 is aryl, and, R2 is unsaturated heterocyclic group which may have one or more, suitable substituent(s) and pharmaceutically acceptable salts, thereof. Also described are the process for preparing these compounds, pharmaceutical compositions containing them and their uses for the treatment of melancholia heart failure, hypertension, renal insufficiency edema, obesity, bronchial asthma, gout hyperuricemia, sudden, infant death syndrome immunosuppression, diabetes, myocardiac infarction thrombosis, obstruction, arteriosclerosis obliterans thrombophlebitis, cerebral infarction, transient ischemic attack or angina …